سوق التأمين ضد الأمراض الخطيرة – السائقين والاتجاهات والفرص وإحصاءات النمو | 2030

  • Report Code : TIPRE00011932
  • Category : Banking, Financial Services, and Insurance
  • Status : Data Released
  • No. of Pages : 150
Buy Now

حجم واتجاهات سوق التأمين ضد الأمراض الخطيرة

من المتوقع أن ينمو حجم سوق التأمين ضد الأمراض الخطيرة من 240.7 مليار دولار أمريكي في عام 2023 إلى 562.9 مليار دولار أمريكي بحلول 2031؛ ومن المتوقع أن يتوسع بمعدل نمو سنوي مركب يبلغ 11.2% من عام 2023 إلى عام 2031. ومن المتوقع أن يؤدي ارتفاع معدل الإصابة بالأمراض الخطيرة مثل أمراض القلب والسرطان والسكتة الدماغية إلى تعزيز نمو سوق التأمين ضد الأمراض الخطيرة.

تحليل سوق التأمين ضد الأمراض الخطيرة

تقود العديد من العوامل الرئيسية سوق التأمين ضد الأمراض الخطيرة. أولاً، هناك وعي متزايد بين الناس والمرضى بشأن فوائد التأمين ضد الأمراض الخطيرة، مما يؤدي إلى زيادة الطلب على التغطية للتخفيف من تكاليف العلاج والتعافي. يعد التكرار المتزايد للأمراض الخطيرة مثل النوبات القلبية والسكتات الدماغية والسرطان أيضًا محركًا مهمًا للسوق.

الحرجة سوق التأمين ضد الأمراض

نظرة عامة

  • التأمين ضد الأمراض الخطيرة هو نوع من خطط التأمين التي توفر دفعة مقطوعة أو فوائد شهرية في حالة تشخيص مرض خطير في المستقبل. تم تصميم هذا النوع من التأمين لتكملة تغطية التأمين الصحي الحالية من خلال توفير أموال إضافية لتلبية المتطلبات التي تأتي مع حالات الطوارئ الصحية المتعلقة بالأمراض الخطيرة.
  • يمكن أن تساعد التغطية في تمويل النفقات التي لا يغطيها التأمين الآخر، مثل النفقات الطبية، وفواتير الأسرة، والتكاليف اليومية التي قد تنشأ بسبب تشخيص الأمراض الخطيرة.
  • بالإضافة إلى ذلك، تزايد عدد كبار السن، والتقدم في التكنولوجيا الطبية، وتحسين معدلات البقاء على قيد الحياة للأمراض الخطيرة يساهمون في نمو السوق.

الرؤى الإستراتيجية

سوق التأمين ضد الأمراض الخطيرة الدوافع والفرص

ارتفاع معدل الإصابة بالأمراض الخطيرة يدفع نمو سوق التأمين ضد الأمراض الخطيرة

< p>

  • يعد الارتفاع المتزايد للأمراض الخطيرة مثل السرطان والسكتة الدماغية وأمراض القلب محركًا مهمًا للسوق. مع زيادة وعي الأفراد بالعبء المالي المرتبط بهذه الأمراض، يزداد الطلب على التغطية التأمينية.
  • وفقًا لتقرير من healthinsurance.org، تغطي معظم وثائق التأمين ضد الأمراض حالات مثل الأزمة القلبية. والسكتة الدماغية وفشل/زراعة الأعضاء والسرطانات الداخلية وغيرها. وتسلط جمعية السرطان الأمريكية الضوء أيضًا على أنه يتم تشخيص إصابة أكثر من 1.7 مليون شخص بالسرطان كل عام في الولايات المتحدة، مما يجعله السبب الرئيسي الثاني للوفاة.
  • مع انتشار هذه الأمراض الخطيرة ومع استمرار الارتفاع، يدرك الأفراد الحاجة إلى الحماية المالية، مما يؤدي إلى زيادة الطلب على التأمين ضد الأمراض الخطيرة.

تحليل تجزئة تقرير سوق التأمين ضد الأمراض الخطيرة

التفاصيل

حجم السوق في عام 2023

240.7 مليار دولار أمريكي

< p>حجم السوق في عام 2031

562.9 مليار دولار أمريكي

معدل النمو السنوي المركب العالمي (2023-2031)

11.2%

البيانات الفعلية

2021 – 2023

فترة التوقعات

2024   2031

تغطية التقرير

حجم السوق وتوقعاته (بالدولار الأمريكي)، ومحركات السوق& تحليل الاتجاهات، وتحليل PEST، والفرص الرئيسية، الإقليمية والعالمية. تحليل الدولة، المشهد التنافسي، ملفات تعريف الشركة

القطاعات المغطاة

النوع (التأمين ضد الأمراض، والتأمين الطبي، وتأمين حماية الدخل)؛ التطبيق (السرطان، الأزمة القلبية، السكتة الدماغية، وغيرها)؛ والجغرافيا.

المناطق المغطاة

أمريكا الشمالية؛ أوروبا؛ آسيا والمحيط الهادئ؛ أمريكا الجنوبية؛ والشرق الأوسط وأفريقيا

البلدان المشمولة

الولايات المتحدة; كندا؛ المكسيك؛ المملكة المتحدة؛ ألمانيا؛ فرنسا، روسيا، إيطاليا؛ الصين؛ الهند؛ اليابان؛ أستراليا؛ كوريا الجنوبية؛ البرازيل؛ الأرجنتين؛ المملكة العربية السعودية؛ الإمارات العربية المتحدة؛ جنوب أفريقيا

قادة السوق والملفات التعريفية الرئيسية للشركة

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What will be the market size for the critical illness insurance market by 2031?

The market is expected to reach US$ 562.9 billion by 2031.

Which are the key players holding the major market share of the critical illness insurance market?

The key players holding majority shares in the market are Aegon N.V.; Allianz SE; Aviva plc; Axa S.A.; and China Life Insurance.

What are the future trends of the critical illness insurance market?

The growing geriatric population is anticipated to play a significant role in the market in the coming years.

What are the driving factors impacting the critical illness insurance market?

The rising incidence of critical illnesses and the growing awareness among people are the major factors that propel the market.

What is the estimated market size for the critical illness insurance market in 2023?

The market was estimated to be US$ 240.7 billion in 2023 and is expected to grow at a CAGR of 11.2% during the forecast period 2023 - 2031.

The List of Companies

  • Aegon N.V.
  • Allianz SE
  • Aviva plc
  • Axa S.A.
  • China Life Insurance
  • China Pacific Insurance Co., Ltd.
  • Legal and General Group plc
  • SBI General Insurance Company Limited
  • Ping An Insurance
  • Prudential plc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports